Targets and therapies for B-cell non-Hodgkin's lymphoma (B-NHL) within the context of the 10 hallmarks of cancer and overlapping oncogenic signaling pathways

Targets and therapies for B-cell non-Hodgkin's lymphoma (B-NHL) within the context of the 10 hallmarks of cancer and overlapping oncogenic signaling pathways. (A) B-cell antigen receptor (BCR) composed of membrane immunoglobulin and associated Igα/Igβ (CD79a/CD79b) when bound to antigen (Ag) leads to BCR aggregation, while the α-β heterodimer transduces signals that rapidly activate Src family kinases Lyn (Blk and Fyn) and immediate downstream tyrosine kinases spleen tyrosine kinase (Syk) and Bruton's tyrosine kinase (Btk), initiating a complex signaling cascade involving multiple adaptors, protein kinases, phosphatases, GTPases, and transcription factors that result in distinct consequences, including differentiation, survival, apoptosis, proliferation, and tolerance. Negative feedback loops that regulate BCR signaling (Lyn/CD22/Shp-1 pathway, SHIP, Cbl, Dok-1, Dok-3, FcγRIIB1, PIR-B, and BCR internalization) are not included in figure. In aggressive B-NHL, uncontrolled activation and proliferation of B-cells resulting from chronic active BCR signaling have been targeted and include (1) Syk (fostamatinib), (2) Btk (PCI-32765), (3) protein kinase C beta (PCKβ; enzastaurin), and (4) mammalian target of rapamycin (mTOR; temsirolimus, everolimus, deferolimus), highlighted in green with red inhibitor sign. Therapeutic targets in orange with red inhibitor sign with question mark are targets in B-NHL for which drugs are or may be available for evaluation in clinical trials. The aberrantly activated nuclear factor kappa B (NF-κB) pathway has been targeted by overwhelming stress response by inhibiting (5) proteasome (bortezomib). Insensitivity to growth inhibitory signaling by epigenetic modulation has been evaluated by blocking (6) histone deacytelace (vorinostat, mocetinostat). Targeting other epigenetic enzymes such as DNA methyltrasferase (DNMT) is of interest, particularly as combinations. Agents promoting apoptosis (7) BCL2/BCLXL (ABT263) have entered clinical trials with promising activity. (B) Limitless replicative potential can be halted by inhibiting cell-cycle kinases (8) G1-S-G2 phase (cyclin-dependent kinases, checkpoint kinases) and (9) M phase (Aurora A/B). (C) Key hallmarks in the extracellular-stromal compartment critical for targeted therapies include (10) immune evasion (lenalidomide; inhibits T regulatory cells [Tregs]), invasion, and metastasis; neo-angiogenesis (bevacizumab, vascular endothelial growth factor receptor/platelet-derived growth factor receptor tyrosine kinase inhibitors); cytokines (AMD3100); and tumor-stroma interactions. BCAP, B-cell adaptor for phosphatidylinositol 3-kinase; PI3K, phosphoinositide 3-kinase; PLCγ2, phospholipase C gamma 2; BLNK, B-cell linker; GRB2, growth factor receptor-bound protein 2; LAB, linker of activated B cells; SOS, son of sevenless; CARMA1, Caspase recruitment domain–containing membrane-associated guanylate kinase protein 1; MALT, mucosa-associated lymphoid tissue; IKK, IκB kinase; TSC2, tuberous sclerosis protein 2; Me, methyl; His, histone; HDAC, histone deacetylase acetylation.
Targets and therapies for B-cell non-Hodgkin's lymphoma (B-NHL) within the context of the 10 hallmarks of cancer and overlapping oncogenic signaling pathways

Publication

Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma. (2011) Daruka Mahadevan, et al. J Clin Oncol. 2011 May 10;29(14):1876-1884. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Drosophila melanogaster Invertebrates Ag AG ncbigene_symbol ag 44501
Drosophila melanogaster Invertebrates AKT AKT ncbigene_symbol Akt 41957
Drosophila melanogaster Invertebrates Btk BTK ncbigene_symbol Btk 34132
Drosophila melanogaster Invertebrates sos SOS ncbigene_symbol Sos 34790
Drosophila melanogaster Invertebrates Rheb RHEB ncbigene_symbol Rheb 117332
Drosophila melanogaster Invertebrates Ras RAS ncbigene_symbol ras 43873
Drosophila melanogaster Invertebrates Ras RAS ncbigene_synonym Ras64B 38494
Drosophila melanogaster Invertebrates Ras RAS ncbigene_synonym Ras85D 41140
Drosophila melanogaster Invertebrates GSK GSK ncbigene_synonym sgg 31248
Drosophila melanogaster Invertebrates MTOR MTOR ncbigene_symbol Mtor 36264
Drosophila melanogaster Invertebrates MTOR MTOR ncbigene_synonym Tor 47396
Drosophila melanogaster Invertebrates IкK IK ncbigene_synonym cact 34969
Drosophila melanogaster Invertebrates NF-KB NF-KB ncbigene_synonym Dif 35045
Drosophila melanogaster Invertebrates NF-KB NF-KB ncbigene_synonym dl 35047
Drosophila melanogaster Invertebrates NF-KB NF-KB ncbigene_synonym Rel 41087
Drosophila melanogaster Invertebrates DNMT DNMT ncbigene_synonym Mt2 34632
Drosophila melanogaster Invertebrates DNMT DNMT ncbigene_synonym Nmt 38909
Drosophila melanogaster Invertebrates HDAC HDAC ncbigene_synonym HDAC4 32278
Drosophila melanogaster Invertebrates HDAC HDAC ncbigene_synonym HDAC6 32461
Drosophila melanogaster Invertebrates HDAC HDAC ncbigene_synonym HDAC1 38565
Drosophila melanogaster Invertebrates HDAC HDAC ncbigene_synonym HDAC3 44446
Homo sapiens Primates Lyn LYN ncbigene_symbol LYN 4067
Homo sapiens Primates BCAP BCAP ncbigene_synonym PHF11 51131
Homo sapiens Primates BCAP BCAP ncbigene_synonym PIK3AP1 118788
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates Btk BTK ncbigene_symbol BTK 695
Homo sapiens Primates sos SOS ncbigene_synonym XYLT2 64132
Homo sapiens Primates sos SOS famplex_relations SOS1 6654
Homo sapiens Primates sos SOS famplex_relations SOS2 6655
Homo sapiens Primates Rheb RHEB ncbigene_symbol RHEB 6009
Homo sapiens Primates Rheb RHEB ncbigene_synonym RHEBP1 6008
Homo sapiens Primates Ras RAS famplex_relations KRAS 3845
Homo sapiens Primates Ras RAS famplex_relations HRAS 3265
Homo sapiens Primates Ras RAS famplex_relations NRAS 4893
Homo sapiens Primates GSK3 GSK3 famplex_relations GSK3A 2931
Homo sapiens Primates GSK3 GSK3 famplex_relations GSK3B 2932
Homo sapiens Primates MTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates IкK IK ncbigene_symbol IK 3550
Homo sapiens Primates NF-KB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates DNMT DNMT ncbigene_synonym DNMT1 1786
Homo sapiens Primates DNMT DNMT famplex_relations DNMT3A 1788
Homo sapiens Primates DNMT DNMT famplex_relations DNMT3B 1789
Homo sapiens Primates DNMT DNMT famplex_relations DNMT3L 29947
Homo sapiens Primates HDAC HDAC ncbigene_synonym HDAC9 9734
Homo sapiens Primates HDAC HDAC famplex_relations HDAC1 3065
Homo sapiens Primates HDAC HDAC famplex_relations HDAC2 3066
Homo sapiens Primates HDAC HDAC famplex_relations HDAC3 8841
Homo sapiens Primates HDAC HDAC famplex_relations HDAC8 55869
Homo sapiens Primates HDAC HDAC famplex_relations HDAC4 9759
Homo sapiens Primates HDAC HDAC famplex_relations HDAC5 10014
Homo sapiens Primates HDAC HDAC famplex_relations HDAC7 51564
Homo sapiens Primates HDAC HDAC famplex_relations HDAC6 10013
Homo sapiens Primates HDAC HDAC famplex_relations HDAC10 83933
Homo sapiens Primates HDAC HDAC famplex_relations SIRT1 23411
Homo sapiens Primates HDAC HDAC famplex_relations SIRT2 22933
Homo sapiens Primates HDAC HDAC famplex_relations SIRT3 23410
Homo sapiens Primates HDAC HDAC famplex_relations SIRT4 23409
Homo sapiens Primates HDAC HDAC famplex_relations SIRT5 23408
Homo sapiens Primates HDAC HDAC famplex_relations SIRT6 51548
Homo sapiens Primates HDAC HDAC famplex_relations SIRT7 51547
Homo sapiens Primates HDAC HDAC famplex_relations HDAC11 79885

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID
Cancer NA